🕵️ Encompass Health Corp ($EHC)
SEC insider & ownership activity, last 12 months · CIK 785161 · every row links its SEC filing
Over the last 12 months insiders sold $21.5M with no open-market buying against it. Mark Tarr sold $16.7M (Feb). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 4 sellers, $21.5M (13 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Mark Tarr | 0 | – | 7 | $16.7M | Feb 11, 2026 |
| Douglas Edward Coltharp | 0 | – | 2 | $3.0M | May 15, 2026 |
| Fay Edmund | 0 | – | 1 | $1.3M | Mar 9, 2026 |
| Patrick Tuer | 0 | – | 3 | $499K | May 11, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Vanguard Capital Management | 5.3% | 13G | Apr 29, 2026 | filing ↗ | |
| Vanguard Portfolio Management | 5.0% | 13G | Apr 29, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Douglas Edward Coltharp | $3.0M | May 15, 2026 | filing ↗ |
| Patrick Tuer | $71K | May 11, 2026 | filing ↗ |
| Mark Tarr | $16.7M | Feb 11, 2026 | filing ↗ |
| Patrick Tuer | $302K | Feb 10, 2026 | filing ↗ |
| Patrick Tuer | $126K | Aug 27, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | May 29, 2026 | filing ↗ |
| New financial obligation (2.03) | May 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 29, 2026 | filing ↗ |
| Material agreement (1.01) | May 14, 2026 | filing ↗ |
| Other events (8.01) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 7, 2026 | filing ↗ |
| Earnings (2.02) | Apr 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 30, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 9, 2026 | filing ↗ |
| Agreement terminated (1.02) | Mar 9, 2026 | filing ↗ |
| New financial obligation (2.03) | Mar 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 9, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 19, 2026 | filing ↗ |
| Earnings (2.02) | Feb 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 5, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 1, 2025 | filing ↗ |
| Earnings (2.02) | Oct 29, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 29, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 29, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 17, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 12, 2025 | filing ↗ |
| Earnings (2.02) | Aug 4, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 4, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 4, 2025 | filing ↗ |